XML 26 R11.htm IDEA: XBRL DOCUMENT
v3.19.1

Inventories | 3 Months Ended
--- | ---
Mar. 31, 2019
Inventory Disclosure [Abstract] |
Inventories | INVENTORIES
(Dollars in Millions) |  | March 31, 2019 |  | December 30, 2018
Raw materials and supplies |  | $ | 1,177 |  |  | 1,114 |
Goods in process |  | 2,081 |  |  | 2,109 |
Finished goods |  | 5,828 |  |  | 5,376 |
Total inventories(1) |  | $ | 9,086 |  |  | 8,599 |
(1) Net of assets held for sale on the Consolidated Balance Sheet for approximately $0.2 billion related to the divestiture of the Advanced Sterilization Products business and $0.2 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of March 31, 2019. Net of assets held for sale of approximately $0.2 billion related to the divestiture of the Advanced Sterilization Products business and $0.3 billion related to the strategic collaboration with Jabil Inc., both of which were pending as of December 30, 2018.

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -URI http://asc.fasb.org/topic&trid=2126998 + Details
Name: | us-gaap_InventoryDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration